t

Real improvement. Real-life benefits—without surgery.

Experience the benefits of spinal stimulation without surgery. ANEUVO ExaStim® Therapy helps to improve loss of hand sensation and strength due to spinal cord injury (SCI)—without requiring medical procedures, downtime, or recovery.

Wavelengths
Wavelengths

Therapy that meets you where you are.

Spinal cord injuries affect everyone differently—but regardless of where you are in your recovery, it is possible to improve your therapy results with ExaStim, a noninvasive device that provides electrical stimulation to the body via a flexible, adhesive multi-electrode pad. This method of therapy is called transcutaneous spinal stimulation, or TSS, and it works by stimulating nerves in the spinal cord, helping to re-activate neural pathways that may have been disrupted by injury.

ExaStim was developed to help people with SCI regain lost movement, strength, and functionality. When used in combination with your rehabilitation program, ExaStim amplifies your efforts, for better results.

Technology

Technology that moves with you.

The technology behind ExaStim was developed through scientific research, clinical collaboration and consultation with people impacted by SCI. The system was designed to be flexible, portable, and simple to use. Clinicians can adjust therapy settings through an intuitive cloud-based application on a touchscreen tablet, enabling more connected care between users and their care teams. People who use ExaStim receive spinal stimulation via a flexible electrode pad that adheres to the skin and moves with the body. ExaStim is a simple, non-invasive therapy designed for easy, everyday use, with proven results and clinical studies showing it is safe and effective.

Learn More

The technology behind ExaStim was developed through scientific research, clinical collaboration and consultation with people impacted by SCI. The system was designed to be flexible, portable, and simple to use. Clinicians control therapy settings using an intuitive app on a touchscreen tablet. People who use ExaStim receive spinal stimulation via a flexible electrode pad that adheres to the skin and moves with the body. ExaStim is a simple, non-invasive therapy designed for easy, everyday use, with proven results and clinical studies showing it is safe and effective.

Learn More

The technology behind ExaStim was developed through scientific research, clinical collaboration and consultation with people impacted by SCI. The system was designed to be flexible, portable, and simple to use. Clinicians control therapy settings using an intuitive app on a touchscreen tablet. People who use ExaStim receive spinal stimulation via a flexible electrode pad that adheres to the skin and moves with the body. ExaStim is a simple, non-invasive therapy designed for easy, everyday use, with proven results and clinical studies showing it is safe and effective.

Learn More

The technology behind ExaStim was developed through scientific research, clinical collaboration and consultation with people impacted by SCI. The system was designed to be flexible, portable, and simple to use. Clinicians control therapy settings using an intuitive app on a touchscreen tablet. People who use ExaStim receive spinal stimulation via a flexible electrode pad that adheres to the skin and moves with the body. ExaStim is a simple, non-invasive therapy designed for easy, everyday use, with proven results and clinical studies showing it is safe and effective.

Learn More

The results are in.

87% of patients were satisfied using ExaStim.

We’re excited about the results of our clinical trials—and our patients are, too. Here are a few highlights:

87% of patients were satisfied with their experience using ExaStim.

26 of 30 patients ranked their experience with ExaStim as 5 or greater.

*Results from ASPIRE Home Study.

96% of patients reported feeling confident in using the ExaStim Stimulation System in their home.

29 of 30 patients ranked their confidence in using ExaStim at home as 5 or greater.

*Results from ASPIRE Home Study.

Learn more about study results.

Explore

Access technical support for ExaStim® users and their caregivers.

Get Support

The Company

At ANEUVO, we share a common goal: to help restore functional independence, improve quality of life, and create a healthier, more equitable world for people living with disabling diseases and conditions.

Learn More

Find out if you’re a candidate for ExaStim® Therapy.

Contact Us
Wavelengths

Real people. Real results.

Read what clinicians and people with lived experience have to say about ANEUVO and the ExaStim Stimulation System.

“I feel slightly stronger and my range of motion might be a little bit better. Like I feel like I can reach an itch on my head a bit better. My ability to pick up small objects is sort of improved too. I can’t pinch, but tendonesis may be stronger.”

Kyle K., Patient

“Overall, I loved using the device. It provided me with such great feedback and input with stimulation, and I thought my hand function improved greatly!”

Larry B., Patient

“My experience with the ExaStim device was extraordinary. After four weeks of use, I saw a significant increase in my ability to manipulate objects with my hands that hadn’t been present before. Just as important, in the short period of time I participated in the study I realized a marked improvement in sensation.

Jamison B., Patient

“Overall, I highly recommend patients try ExaStim. It takes a little getting used to, but the results were incredible after using it for only 4 weeks. As a quadriplegic, the most life-changing result would be to regain any amount of hand/wrist function — and ANEUVO made that a reality! I look forward to using the device again in the future!”

Sean H., Patient

“Having a highlevel SCI, my son’s deepest desire has not been to walk but rather to have functioning hands again. In only 4 weeks, ExaStim has allowed him to hold and pour a drink into his own mouth!” 

Anonymous, Caregiver

If this brought more independence in as little as one month, it is extremely exciting to think of what it will do with prolonged use! Thank you, ANEUVO for restoring hope and some function!

Stephanie J., Caregiver

“As a neuro physical therapist specializing in spinal cord injury rehabilitation, I highly recommend the ExaStim Trans Spinal Stimulation (TSS) device by ANEUVO as a cutting-edge adjunct to activity-based therapy.”

Sakina V., Therapist

“After only a month using this TSS for an average of 3 times a week at an hour each, the ExaStim has given me the independence to pick up a cup and drink without a straw for the first time in years!”

Sean H., Patient

“It alleviated that warm-up need when doing activities. Because of the sensory aspect, I felt the motion was more fluid. I may not have been able to do more, but the movements I could do were more fluid. One of the best things about doing this at home was helping my family cook food with the stimulation on — I was able to cut up beets and put them on the slicer.” 

Tony S., Patient

“ANEUVO offers something unique to chronic cervical spinal sufferers. It offers hope. The device and the stimulation provided a spark that started to make certain movements possible and other movements easier. Since its transcutaneous, it’s non-invasive and there’s really no reason to not at least try the stim.” 

Dan S., Patient

ANEUVO in the News

ANEUVO has been featured by leading news networks, business and health podcasts, and science and research conferences around the world. Learn more about our company, our technology, and individuals’ experiences with transcutaneous spinal stimulation and the ExaStim Stimulation System in the stories below.

ANEUVO Receives FDA Clearance for ExaStim<sup><sup>®</sup></sup>

ANEUVO Receives FDA Clearance for ExaStim®

U.S. market entry furthers global mission for accessible clinical and at-home non-invasive neuromodulation therapy Los Angeles, CA, April 16, 2026 (GLOBE NEWSWIRE) -- ANEUVO, a...

Read more
ANEUVO Receives FDA Clearance for ExaStim<sup><sup>®</sup></sup>

ANEUVO Receives FDA Clearance for ExaStim®

U.S. market entry furthers global mission for accessible clinical and at-home non-invasive neuromodulation therapy Los Angeles, CA, April 16, 2026 (GLOBE NEWSWIRE) -- ANEUVO, a...

Read more
Investigational therapy helps Easthampton man regain movement after spinal cord injury

Investigational therapy helps Easthampton man regain movement after spinal cord injury

EASTHAMPTON, MA (WGGB/WSHM) -- Nearly a decade after a training ride crash left him with a spinal cord injury, an Easthampton man is regaining function...

Read more
ANEUVO Secures Series C Funding to Strengthen ExaStim<sup>®</sup> Regulatory Readiness and Global Operational Scale

ANEUVO Secures Series C Funding to Strengthen ExaStim® Regulatory Readiness and Global Operational Scale

Proceeds to support manufacturing growth, regulatory advancement, and disciplined commercialization expansion Los Angeles, CA, March 05, 2026 (GLOBE NEWSWIRE) -- ANEUVO, a medical technology company...

Read more
ANEUVO Recognized with Taiwan’s 22nd National Innovation Award for ExaStim<sup>®</sup> Neuromodulation Technology

ANEUVO Recognized with Taiwan’s 22nd National Innovation Award for ExaStim® Neuromodulation Technology

Honor highlights international startup advancing non-invasive rehabilitation technology for people living with chronic spinal cord injury Los Angeles, CA, Feb. 11, 2026 (GLOBE NEWSWIRE) --...

Read more
ANEUVO Showcases ExaStim<sup>®</sup> Therapy At RehaCare 2025 and ISCoS 2025

ANEUVO Showcases ExaStim® Therapy At RehaCare 2025 and ISCoS 2025

The first MDR-Approved Non-Invasive Spinal Stimulation System in Europe Los Angeles, CA, Sept. 16, 2025 (GLOBE NEWSWIRE) -- ANEUVO today announced its participation in two...

Read more
ANEUVO’s ExaStim<sup>®</sup> Earns CE Mark Certification

ANEUVO’s ExaStim® Earns CE Mark Certification

Key Milestone Signals Readiness for European Market Entry and Commitment to Quality Los Angeles, CA, April 09, 2025 (GLOBE NEWSWIRE) -- ANEUVO, a pioneer in...

Read more
ANEUVO Launches ASPIRE<sup>™</sup> Home Study to Evaluate Home Use of ExaStim<sup>®</sup>

ANEUVO Launches ASPIRE Home Study to Evaluate Home Use of ExaStim®

This new phase of clinical research will test the safety and feasibility of ANEUVO’s non-invasive therapy for future use by individuals living with chronic spinal...

Read more
View More

[1] Taylor C, McHugh C, Mockler D, Minogue C, Reilly RB, Fleming N. (2021) Transcutaneous spinal cord stimulation and motor responses in individuals with spinal cord injury: A methodological review. PLoS One. 2021 Nov 18;16(11):e0260166.

[2] Gerasimenko, Y., Sayenko, D., Gad, P., & Edgerton, V. R. (2021). Transcutaneous spinal cord stimulation: Advances in mechanisms and clinical applications for spinal cord injury rehabilitation. Frontiers in Cellular Neuroscience, 15, 1095259.

[3] Zhu, M., Wei, Y., Xiang, X., & Li, Y. (2022). The application of transcutaneous spinal cord stimulation in improving movement function after spinal cord injury: A review. Neural Plasticity, 9267622.

[4] Benavides, F. D., Jo, H., Li, X., & Contreras-Vidal, J. L. (2021). The role of transcutaneous spinal cord stimulation in motor recovery after spinal cord injury: A systematic review. Biomedical Journal, 11(8).

[5] Seáñez, I., Capogrosso, M. Motor improvements enabled by spinal cord stimulation combined with physical training after spinal cord injury: review of experimental evidence in animals and humans. Bioelectron Med 7, 16 (2021). https://doi.org/10.1186/s42234-021-00077-5.